Reporting of rejection after renal transplantation in large immunosuppressive trials: Biopsy-proven, clinical, presumed, or treated rejection?

Transplantation

Volumn 81, Issue 5, 2006, Pages 655-659

  Fleiner, Franca ^a   Fritsche, Lutz ^a   Glander, Petra ^a   Neumayer, Hans H ^a   Budde, Klemens ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Immunosuppression; Randomized controlled trial; Renal transplantation; Reporting quality

Indexed keywords

BASILIXIMAB; CYCLOSPORIN; DACLIZUMAB; RAPAMYCIN; TSUKUBAENOLIDE;

ACUTE GRAFT REJECTION; ARTICLE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFORMATION; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; PERFORMANCE; PRIORITY JOURNAL; PUBLICATION; SCIENTIFIC LITERATURE;

BIOPSY; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MULTICENTER STUDIES; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 33645084814     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000214933.73927.4e     Document Type: Article

References (11)

1. Fritsche L, Einecke G, Heiner F, et al. Reports of large immunosuppression trials in kidney transplantation: room for improvement. Am J Transplant 2004; 4: 738.
2. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001; 134: 657.
3. Morris PJ. Quality of Randomised Trials in Solid Organ transplantation. Transplantation 2005; 80: 431.
4. Pengel L, Barcena L, Morris PJ. Registry of randomized controlled trials in transplantation. Transplantation 2005; 80: 432.
5. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
6. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
7. Barcena L, Pengel L, Morris PJ. Reporting of randomized controlled trials in transplantation. Transplantation 2005; 80: 1525.
8. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation 1996; 15;61: 1029.
9. Gray DW, Richardson A, Hughes D, et al. A prospective, randomised, blind comparison of three biopsy techniques in the management of patients after renal transplantation. Transplantation 1992; 53: 1226.
10. Budde K, Fritsche L. Proposal for guidelines for publication of randomized trials in the American Journal of Transplantation. Am J Transplant 2005; 5: 644.
11. Remuzzi G, Lesti M, Gotti E, et al. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomized trial. Lancet 2004; 364: 503.